Woodline Partners LP Akouos, Inc. Transaction History

Woodline Partners LP

  • $9.97 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$17.03 - $22.45 $5.55 Million - $7.31 Million
-325,831 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$19.3 - $26.92 $131,587 - $183,540
6,818 Added 2.14%
325,831 $7.45 Million
Q2 2020

Aug 14, 2020
BUY
$22.0 - $22.5 $7.02 Million - $7.18 Million
319,013 New
319,013 $7.18 Million

About Akouos, Inc.

AKUS Quotes by TradingView
  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email